Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eye

被引:77
作者
Jaruratanasirikul, S
Hortiwakul, R
Tantisarasart, T
Phuenpathom, N
Tussanasunthornwong, S
机构
[1] PRINCE SONGKLA UNIV,FAC MED,DEPT OPHTHALMOL,SONGKHLA 90112,THAILAND
[2] PRINCE SONGKLA UNIV,FAC MED,DEPT SURG,SONGKHLA 90112,THAILAND
关键词
D O I
10.1128/AAC.40.3.825
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
To measure the concentrations of azithromycin in the central nervous system, 20 patients with brain tumors (group I) received a single 500-mg oral dose of azithromycin either 24, 48, 72, or 96 h prior to the tumor removal operation and 10 patients with cataracts undergoing surgery (group II) and 7 patients scheduled to undergo lumbar puncture (group III) received the same dose of azithromycin 24 h prior to the operation or procedure. Serum from all patients, brain tissue from group I, aqueous humor from group II, and cerebrospinal fluid from group III were assayed for azithromycin concentration. The mean concentrations of azithromycin in brain tissue 24, 48, 72, and 96 h after administration were 2.63 +/- 2.58, 3.64 +/- 3.81, 0.74 +/- 0.37, and 0.41 mu g/g, respectively. In contrast, the concentrations of azithromycin in cerebrospinal fluid and aqueous humor of the eye were very low or undetectable. Therefore, these data show that azithromycin appears to be widely distributed into brain tissue but not into cerebrospinal fluid or aqueous humor of the eye.
引用
收藏
页码:825 / 826
页数:2
相关论文
共 8 条
[1]
AZITHROMYCIN, A MACROLIDE ANTIBIOTIC WITH POTENT ACTIVITY AGAINST TOXOPLASMA-GONDII [J].
ARAUJO, FG ;
GUPTILL, DR ;
REMINGTON, JS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :755-757
[2]
INVIVO ACTIVITY OF THE MACROLIDE ANTIBIOTICS AZITHROMYCIN, ROXITHROMYCIN AND SPIRAMYCIN AGAINST TOXOPLASMA-GONDII [J].
ARAUJO, FG ;
SHEPARD, RM ;
REMINGTON, JS .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (06) :519-524
[3]
ACTIVITY INVITRO AGAINST TOXOPLASMA-GONDII OF AZITHROMYCIN AND CLARITHROMYCIN ALONE AND WITH PYRIMETHAMINE [J].
DEROUIN, F ;
CHASTANG, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 (04) :708-711
[4]
CONCENTRATIONS OF AZITHROMYCIN IN HUMAN TONSILLAR TISSUE [J].
FOULDS, G ;
CHAN, KH ;
JOHNSON, JT ;
SHEPARD, RM ;
JOHNSON, RB .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (10) :853-856
[5]
INVITRO AND INVIVO UPTAKE OF AZITHROMYCIN (CP-62,993) BY PHAGOCYTIC-CELLS - POSSIBLE MECHANISM OF DELIVERY AND RELEASE AT SITES OF INFECTION [J].
GLADUE, RP ;
BRIGHT, GM ;
ISAACSON, RE ;
NEWBORG, MF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (03) :277-282
[6]
THE PHARMACOKINETICS OF AZITHROMYCIN AND THEIR CLINICAL-SIGNIFICANCE [J].
LODE, H .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (10) :807-812
[7]
AZITHROMYCIN - A REVIEW OF ITS ANTIMICROBIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND CLINICAL EFFICACY [J].
PETERS, DH ;
FRIEDEL, HA ;
MCTAVISH, D .
DRUGS, 1992, 44 (05) :750-799
[8]
SPECTRUM OF ACTIVITY OF AZITHROMYCIN [J].
WILLIAMS, JD .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (10) :813-820